▶ 調査レポート

世界の多形性膠芽腫の治療市場：市場規模・現状・予測
• 英文タイトル：Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の多形性膠芽腫の治療市場：市場規模・現状・予測 / Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7246資料のイメージです。• レポートコード：QYR9N7246
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、多形性膠芽腫の治療のグローバル市場について調査・分析したレポートで、種類別（ベバシズマブ（アバスチン）、カルムスチン（BiCNU）、テモゾロマイド（テモダールとテモダルとテマド））、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・多形性膠芽腫の治療の世界市場規模
・主要企業別市場シェア
・多形性膠芽腫の治療の世界市場規模：種類別（ベバシズマブ（アバスチン）、カルムスチン（BiCNU）、テモゾロマイド（テモダールとテモダルとテマド））
・多形性膠芽腫の治療の世界市場規模：用途別（病院、診療所、その他）
・多形性膠芽腫の治療のアメリカ市場規模（種類別、用途別）
・多形性膠芽腫の治療のヨーロッパ市場規模（種類別、用途別）
・多形性膠芽腫の治療の中国市場規模（種類別、用途別）
・多形性膠芽腫の治療の日本市場規模（種類別、用途別）
・多形性膠芽腫の治療の東南アジア市場規模（種類別、用途別）
・多形性膠芽腫の治療のインド市場規模（種類別、用途別）
・多形性膠芽腫の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・多形性膠芽腫の治療の世界市場予測（2019年-2025年）
・多形性膠芽腫の治療の地域別市場予測（2019年-2025年）
...

In 2018, the global Glioblastoma Multiforme Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glioblastoma Multiforme Treatment development in United States, Europe and China.

The key players covered in this study
AbbVie, Inc
Activartis GmbH
Agenus Inc
Arog Pharmaceuticals, Inc
Bristol-Myers Squibb Company
Cavion LLC
Celldex Therapeutics Inc
Cortice Biosciences
Exelixis Inc
F. Hoffmann-La Roche Ltd.

Market segment by Type, the product can be split into
Bevacizumab (Avastin)
Carmustine (BiCNU)
Temozolomide (Temodar and Temodal and Temcad)

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Glioblastoma Multiforme Treatment status, future forecast, growth opportunity, key market and key players.
To present the Glioblastoma Multiforme Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Glioblastoma Multiforme Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Bevacizumab (Avastin)
1.4.3 Carmustine (BiCNU)
1.4.4 Temozolomide (Temodar and Temodal and Temcad)
1.5 Market by Application
1.5.1 Global Glioblastoma Multiforme Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Glioblastoma Multiforme Treatment Market Size
2.2 Glioblastoma Multiforme Treatment Growth Trends by Regions
2.2.1 Glioblastoma Multiforme Treatment Market Size by Regions (2014-2025)
2.2.2 Glioblastoma Multiforme Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Glioblastoma Multiforme Treatment Market Size by Manufacturers
3.1.1 Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Glioblastoma Multiforme Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Glioblastoma Multiforme Treatment Key Players Head office and Area Served
3.3 Key Players Glioblastoma Multiforme Treatment Product/Solution/Service
3.4 Date of Enter into Glioblastoma Multiforme Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Glioblastoma Multiforme Treatment Market Size by Type (2014-2019)
4.2 Global Glioblastoma Multiforme Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Glioblastoma Multiforme Treatment Market Size (2014-2019)
5.2 Glioblastoma Multiforme Treatment Key Players in United States
5.3 United States Glioblastoma Multiforme Treatment Market Size by Type
5.4 United States Glioblastoma Multiforme Treatment Market Size by Application

6 Europe
6.1 Europe Glioblastoma Multiforme Treatment Market Size (2014-2019)
6.2 Glioblastoma Multiforme Treatment Key Players in Europe
6.3 Europe Glioblastoma Multiforme Treatment Market Size by Type
6.4 Europe Glioblastoma Multiforme Treatment Market Size by Application

7 China
7.1 China Glioblastoma Multiforme Treatment Market Size (2014-2019)
7.2 Glioblastoma Multiforme Treatment Key Players in China
7.3 China Glioblastoma Multiforme Treatment Market Size by Type
7.4 China Glioblastoma Multiforme Treatment Market Size by Application

8 Japan
8.1 Japan Glioblastoma Multiforme Treatment Market Size (2014-2019)
8.2 Glioblastoma Multiforme Treatment Key Players in Japan
8.3 Japan Glioblastoma Multiforme Treatment Market Size by Type
8.4 Japan Glioblastoma Multiforme Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2014-2019)
9.2 Glioblastoma Multiforme Treatment Key Players in Southeast Asia
9.3 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type
9.4 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application

10 India
10.1 India Glioblastoma Multiforme Treatment Market Size (2014-2019)
10.2 Glioblastoma Multiforme Treatment Key Players in India
10.3 India Glioblastoma Multiforme Treatment Market Size by Type
10.4 India Glioblastoma Multiforme Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Glioblastoma Multiforme Treatment Market Size (2014-2019)
11.2 Glioblastoma Multiforme Treatment Key Players in Central & South America
11.3 Central & South America Glioblastoma Multiforme Treatment Market Size by Type
11.4 Central & South America Glioblastoma Multiforme Treatment Market Size by Application

12 International Players Profiles
12.1 AbbVie, Inc
12.1.1 AbbVie, Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glioblastoma Multiforme Treatment Introduction
12.1.4 AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.1.5 AbbVie, Inc Recent Development
12.2 Activartis GmbH
12.2.1 Activartis GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glioblastoma Multiforme Treatment Introduction
12.2.4 Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.2.5 Activartis GmbH Recent Development
12.3 Agenus Inc
12.3.1 Agenus Inc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glioblastoma Multiforme Treatment Introduction
12.3.4 Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.3.5 Agenus Inc Recent Development
12.4 Arog Pharmaceuticals, Inc
12.4.1 Arog Pharmaceuticals, Inc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glioblastoma Multiforme Treatment Introduction
12.4.4 Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.4.5 Arog Pharmaceuticals, Inc Recent Development
12.5 Bristol-Myers Squibb Company
12.5.1 Bristol-Myers Squibb Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Glioblastoma Multiforme Treatment Introduction
12.5.4 Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.5.5 Bristol-Myers Squibb Company Recent Development
12.6 Cavion LLC
12.6.1 Cavion LLC Company Details
12.6.2 Company Description and Business Overview
12.6.3 Glioblastoma Multiforme Treatment Introduction
12.6.4 Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.6.5 Cavion LLC Recent Development
12.7 Celldex Therapeutics Inc
12.7.1 Celldex Therapeutics Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Glioblastoma Multiforme Treatment Introduction
12.7.4 Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.7.5 Celldex Therapeutics Inc Recent Development
12.8 Cortice Biosciences
12.8.1 Cortice Biosciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Glioblastoma Multiforme Treatment Introduction
12.8.4 Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.8.5 Cortice Biosciences Recent Development
12.9 Exelixis Inc
12.9.1 Exelixis Inc Company Details
12.9.2 Company Description and Business Overview
12.9.3 Glioblastoma Multiforme Treatment Introduction
12.9.4 Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.9.5 Exelixis Inc Recent Development
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 F. Hoffmann-La Roche Ltd. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Glioblastoma Multiforme Treatment Introduction
12.10.4 F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)
12.10.5 F. Hoffmann-La Roche Ltd. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Glioblastoma Multiforme Treatment Key Market Segments
Table Key Players Glioblastoma Multiforme Treatment Covered
Table Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type 2014-2025
Figure Bevacizumab (Avastin) Figures
Table Key Players of Bevacizumab (Avastin)
Figure Carmustine (BiCNU) Figures
Table Key Players of Carmustine (BiCNU)
Figure Temozolomide (Temodar and Temodal and Temcad) Figures
Table Key Players of Temozolomide (Temodar and Temodal and Temcad)
Table Global Glioblastoma Multiforme Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Glioblastoma Multiforme Treatment Report Years Considered
Table Global Glioblastoma Multiforme Treatment Market Size 2014-2025 (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Share by Regions 2014-2019
Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2014-2019
Figure Global Glioblastoma Multiforme Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Glioblastoma Multiforme Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Share by Manufacturers (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Market Share by Manufacturers in 2018
Table Global Glioblastoma Multiforme Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Glioblastoma Multiforme Treatment Product/Solution/Service
Table Date of Enter into Glioblastoma Multiforme Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size Share by Type (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Type (2014-2019)
Table Global Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Glioblastoma Multiforme Treatment Market Size Share by Application (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Market Size Market Share by Application (2014-2019)
Figure Global Glioblastoma Multiforme Treatment Revenue Market Share by Application in 2018
Figure United States Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table United States Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table United States Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Europe Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Europe Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Europe Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure China Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table China Glioblastoma Multiforme Treatment Market Size by Type (2014-20189) (Million US$)
Table China Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table China Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table China Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Japan Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Japan Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Japan Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure India Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table India Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table India Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table India Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table India Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Figure Central & South America Glioblastoma Multiforme Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Glioblastoma Multiforme Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Glioblastoma Multiforme Treatment Market Share (2018-2019)
Table Central & South America Glioblastoma Multiforme Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Glioblastoma Multiforme Treatment Market Share by Type (2014-2019)
Table Central & South America Glioblastoma Multiforme Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Glioblastoma Multiforme Treatment Market Share by Application (2014-2019)
Table AbbVie, Inc Company Details
Table AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019) (Million US$)
Figure AbbVie, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table AbbVie, Inc Recent Development
Table Activartis GmbH Company Details
Table Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Activartis GmbH Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Activartis GmbH Recent Development
Table Agenus Inc Company Details
Table Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Agenus Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Agenus Inc Recent Development
Table Arog Pharmaceuticals, Inc Company Details
Table Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Arog Pharmaceuticals, Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Arog Pharmaceuticals, Inc Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Cavion LLC Company Details
Table Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Cavion LLC Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Cavion LLC Recent Development
Table Celldex Therapeutics Inc Company Details
Table Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Celldex Therapeutics Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Celldex Therapeutics Inc Recent Development
Table Cortice Biosciences Company Details
Table Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Cortice Biosciences Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Cortice Biosciences Recent Development
Table Exelixis Inc Company Details
Table Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure Exelixis Inc Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table Exelixis Inc Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Glioblastoma Multiforme Treatment Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Global Glioblastoma Multiforme Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions (2019-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2025
Figure United States Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Glioblastoma Multiforme Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Glioblastoma Multiforme Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size by Product (2019-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size by Product in 2025
Table Global Glioblastoma Multiforme Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Glioblastoma Multiforme Treatment Market Size by Application (2019-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の多形性膠芽腫（GBM）市場：市場規模・現状・予測
    Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2019-2025
    QYR9N7247 2019年6月14日 92Pages
    当資料は、多形性膠芽腫（GBM）のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）、用途別（ベバコズマブ、カルムスティン、テモゾロマイド）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...
  • 世界の多形性膠芽腫（GBM）治療学市場：市場規模・現状・予測
    Global Glioblastoma Multiforme (GBM) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7245 2019年6月14日 99Pages
    当資料は、多形性膠芽腫（GBM）治療学のグローバル市場について調査・分析したレポートで、種類別（化学療法、標的薬物療法、放射線療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測
    Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7541 2019年6月14日 94Pages
    当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界のディンプル形成術の治療市場：市場規模・現状・予測
    Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7109 2019年6月14日 93Pages
    当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界の汗腺炎掻爬治療市場：市場規模・現状・予測
    Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7295 2019年6月14日 99Pages
    当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・汗腺炎...
  • 世界の外側上顆炎治療市場：市場規模・現状・予測
    Global Lateral Epicondylitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7439 2019年6月14日 96Pages
    当資料は、外側上顆炎治療のグローバル市場について調査・分析したレポートで、種類別（非外科療法、外科療法）、用途別（運動選手、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・外側上...
  • 世界の精神神経疾患および治療市場：市場規模・現状・予測
    Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7660 2019年6月14日 97Pages
    当資料は、精神神経疾患および治療のグローバル市場について調査・分析したレポートで、種類別（変性疾患、神経障害、精神病）、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の副甲状腺機能低下症の治療市場：市場規模・現状・予測
    Global Hypoparathyroidism Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7330 2019年6月14日 99Pages
    当資料は、副甲状腺機能低下症の治療のグローバル市場について調査・分析したレポートで、種類別（経口、非経口）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    <...
  • 世界の多形性膠芽腫（GBM）市場：市場規模・現状・予測世界の多形性膠芽腫（GBM）市場：市場規模・現状・予測 Glioblastoma is a fast-growing, aggressive type of central nervous system tumor that forms on the supportive tissue of the brain.Global glioblastoma multiforme treatment market is expected to witness significant growth over the forecast period owing to the rising incidence of oncology diseases and r…
  • 世界の多形性膠芽腫（GBM）治療学市場：市場規模・現状・予測世界の多形性膠芽腫（GBM）治療学市場：市場規模・現状・予測 Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pip…
  • 世界の獣医整形外科治療市場：市場規模・現状・予測世界の獣医整形外科治療市場：市場規模・現状・予測 Animals commonly suffer from different orthopedic conditions that result in abnormal movement, instability, lameness, and others. Orthopedic conditions such as hip dysplasia, elbow dysplasia, patella luxation, and others require a surgical procedure for the treatment of the condition. The treatment …
  • 世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測 Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving g…
  • 世界のうつ病治療市場：市場規模・現状・予測世界のうつ病治療市場：市場規模・現状・予測 Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the t…